Emerging Company Profile
Mega-round meets dealmaker as CBC’s AffaMed readies to build pipeline
Emerging Company Profile: $170M raise led by Lake Bleu gives Ji Li cash to hunt neurology, eye disorder assets
A $170 million series B led by Lake Bleu gives BeiGene veteran Ji Li ample funding to build up the neurology and ophthalmology pipeline of CBC portfolio company AffaMed.
Cross-border company AffaMed now has more than $170 million in series B funding and the backing of Lake Bleu Capital to pair with its hiring of one of China’s most prominent dealmakers, Ji Li, as it seeks to build up its in-licensed pipeline of